Abstract
Some aspects related with the use of furazolidone as a rescue therapy for Helicobacter pylori (H pylori) infection should be remarked, especially regarding its potential oncologic risk. The inclusion of furazolidone in a treatment regimen for H pylori infection is, at least, controversial, and it does not appear to be safe.
Lingua originale | English |
---|---|
pagine (da-a) | 1914-1915 |
Numero di pagine | 2 |
Rivista | World Journal of Gastroenterology |
Volume | 15 |
Stato di pubblicazione | Pubblicato - 2009 |
Pubblicato esternamente | Sì |
Keywords
- Animals
- Anti-Infective Agents, Local
- Drug Toxicity
- Furazolidone
- Helicobacter Infections
- Helicobacter pylori
- Humans
- Salvage Therapy
- Treatment Outcome